INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
RECAP: BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT

RECAP: BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT

Indisputable evidence that Pfizer was asleep at the 'injections' wheel.

Hedley Rees's avatar
Hedley Rees
Apr 17, 2024
∙ Paid
13

Share this post

INSIDE PHARMA
INSIDE PHARMA
RECAP: BROOK JACKSON SPILLS THE BEANS ON LACK OF PFIZER OVERSIGHT
1
Share

THIS IS A RECAP

This is a post from February 2022. I thought to re-share it, as with over two years passing since the post, people appear to be waking up to the Sh1T show that is the pharmaceutical supply chain. Yes, this is about malfeasance in the Pfizer supply chain—nothing to do with science!

Ventavia was one of the many players in the pharmaceutical supply chain involved in carrying out clinical trials for Pfizer. They would receive clinical trial kits from a company producing them somewhere else in the world. If Ventavia didn’t get the trials right, then the supply chain would come to a complete stop. Make your own mind up on whether Ventavia got it right:

BROOK JOINS VENTAVIA

On September 7, 2020, Brook Jackson began her employment with Ventavia Research Group (“Ventavia”) as a Regional Director.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share